Stockreport

OS Therapies Reports Full Year 2024 Financial Results and Provides Business Update [Yahoo! Finance]

OS Therapies Incorporated  (OSTX) 
PDF Rolling BLA submission expected to begin thereafter in order to gain regulatory approval by year-end 2025, triggering issuance of a Priority Review Voucher (PRV) NEW [Read more]